Understanding The Role of CYP2B6 in Drug Metabolism and Distribution

Target Name: CYP2B6

NCBI ID: G1555

CYP2B6

Understanding The Role of CYP2B6 in Drug Metabolism and Distribution

CYP2B6 (CP2B6_HUMAN), a member of the CYP2B6 gene family, is a protein that is primarily expressed in the liver and other organs. It plays a crucial role in the metabolism of a wide variety of drugs, including many statins, antidepressants, and opioids. As a result, CYP2B6 has become an attractive drug target for researchers because of its ability to influence the absorption, distribution, metabolism, and elimination of many drugs.

The CYP2B6 gene is located on chromosome 11 and encodes a protein that consists of 218 amino acids. It is a member of the CYP2B6 gene family, which includes several related genes that are involved in the metabolism of drugs. The CYP2B6 gene is responsible for producing the protein that is involved in the metabolism of many drugs.

CYP2B6 is a transmembrane protein that is expressed in many different tissues and organs, including the liver, heart, and kidneys. It is primarily localized to the endoplasmic reticulum, which is the part of the cell that transports and retrieves proteins from the cytoplasm. Once inside the endoplasmic reticulum, CYP2B6 is retained in the membrane and is involved in the metabolism of drugs.

CYP2B6 is involved in the metabolism of many different drugs, including many statins, antidepressants, and opioids. It is a key enzyme in the metabolism of many of these drugs, and its activity can be affected by a variety of factors, including the dose of the drug, the presence of other drugs or substances, and the user's genetic makeup.

One of the ways that CYP2B6 is involved in the metabolism of drugs is by modifying the way that the drug is metabolized. Many drugs are metabolized by CYP2B6, and the way that they are metabolized can affect their efficacy and side effects. For example, the metabolite of a statin, which is formed when the drug is metabolized by CYP2B6, may have a different effect on the body than the original drug. This is why it is important to carefully monitor the metabolism of drugs when taking them, and to choose the right dose and timing for their use.

CYP2B6 is also involved in the distribution of drugs in the body. The liver is the primary site of drug storage and metabolism in the body, and CYP2B6 is responsible for transmitting the drug from the liver to other organs and tissues. The way that CYP2B6 is expressed and activated in the liver determines where the drug is distributed throughout the body.

CYP2B6 is also involved in the elimination of drugs from the body. The liver is the primary site of drug elimination in the body, and CYP2B6 is responsible for removing the drug from the body. The way that CYP2B6 is expressed and activated in the liver determines where the drug is eliminated from the body.

In conclusion, CYP2B6 is a protein that is involved in the metabolism, distribution, and elimination of many drugs. As a result, it has become an attractive drug target for researchers because of its ability to influence the absorption, distribution, metabolism, and elimination of many drugs. Further research is needed to fully understand the role of CYP2B6 in the metabolism of drugs and to develop effective strategies for targeting it as a drug.

Protein Name: Cytochrome P450 Family 2 Subfamily B Member 6

Functions: A cytochrome P450 monooxygenase involved in the metabolism of endocannabinoids and steroids (PubMed:21289075, PubMed:12865317). Mechanistically, uses molecular oxygen inserting one oxygen atom into a substrate, and reducing the second into a water molecule, with two electrons provided by NADPH via cytochrome P450 reductase (NADPH--hemoprotein reductase). Catalyzes the epoxidation of double bonds of arachidonoylethanolamide (anandamide) to 8,9-, 11,12-, and 14,15-epoxyeicosatrienoic acid ethanolamides (EpETrE-EAs), potentially modulating endocannabinoid system signaling (PubMed:21289075). Hydroxylates steroid hormones, including testosterone at C-16 and estrogens at C-2 (PubMed:21289075, PubMed:12865317). Plays a role in the oxidative metabolism of xenobiotics, including plant lipids and drugs (PubMed:11695850, PubMed:22909231). Acts as a 1,4-cineole 2-exo-monooxygenase (PubMed:11695850)

The "CYP2B6 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about CYP2B6 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets